Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency
Abstract Background Alpha 1 Antitrypsin (AAT) is a key serum proteinase inhibitor encoded by SERPINA1. Sequence variants of the gene can cause Alpha 1 Antitrypsin Deficiency (AATD), a condition associated with lung and liver disease. The majority of AATD cases are caused by the ‘Z’ and ‘S’ variants...
Main Authors: | Friedrich Kueppers, Mark D. Andrake, Qifang Xu, Roland L. Dunbrack, Joannah Kim, Christopher L. Sanders |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-07-01
|
Series: | BMC Medical Genetics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12881-019-0852-5 |
Similar Items
-
Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review
by: Ilaria Ferrarotti, et al.
Published: (2024-02-01) -
Evaluation of Alpha-1 Antitrypsin Levels and SERPINA1 Gene Polymorphisms in Sickle Cell Disease
by: Magda Oliveira Seixas Carvalho, et al.
Published: (2017-11-01) -
Alpha-1 antitrypsin deficiency: outstanding questions and future directions
by: María Torres-Durán, et al.
Published: (2018-07-01) -
Case report of a novel alpha1-antitrypsin null variant in Türkiye: Q0RİZE
by: Dilek Karadoğan, et al.
Published: (2024-02-01) -
Molecular characterization of PI*Shangzhou, a SERPINA1 allele from continental China encoding a defective alpha-1-antitrypsin
by: José M. Hernández-Pérez, et al.
Published: (2022-09-01)